Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Marhold

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Molecular Cancer Research : MCR|October 29, 2014
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem CellsMaximilian Marhold, Erwin Tomasich, Ahmed El-Gazzar, et al.
Life (Basel, Switzerland)|June 26, 2026
Characterization of HER2 Expression Levels, Including HER2-Ultralow, in a Retrospective Male Breast Cancer CohortMaximilian Marhold, Alexa Binder, Zsuzsanna Bago-Horvath, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Breast Cancer Research and Treatment|September 8, 2022
Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patientsConstantin Sajdik, Eva Schuster, Barbara Holzer, et al.
BMC Cancer|October 27, 2022
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in AustriaChristine Deutschmann, Rupert Bartsch, Christian F Singer, et al.
NPJ Breast Cancer|April 17, 2026
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trialsSimon Udovica, Rupert Bartsch, Christian F Singer, et al.
Scientific Reports|January 18, 2014
TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivoPeter Horak, Erwin Tomasich, Petr Vaňhara, et al.
Plos One|March 3, 2023
Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective studyCarmen Leser, Georg Dorffner, Maximilian Marhold, et al.
Oncoimmunology|November 29, 2023
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancerMaximilian Marhold, Simon Udovica, Anna Halstead, et al.
Cancers|February 25, 2023
Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast CancerEva Welsch, Eva Schuster, Michael Krainer, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Molecular Cancer Research : MCR|October 29, 2014
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem CellsMaximilian Marhold, Erwin Tomasich, Ahmed El-Gazzar, et al.
Life (Basel, Switzerland)|June 26, 2026
Characterization of HER2 Expression Levels, Including HER2-Ultralow, in a Retrospective Male Breast Cancer CohortMaximilian Marhold, Alexa Binder, Zsuzsanna Bago-Horvath, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Breast Cancer Research and Treatment|September 8, 2022
Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patientsConstantin Sajdik, Eva Schuster, Barbara Holzer, et al.
BMC Cancer|October 27, 2022
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in AustriaChristine Deutschmann, Rupert Bartsch, Christian F Singer, et al.
NPJ Breast Cancer|April 17, 2026
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trialsSimon Udovica, Rupert Bartsch, Christian F Singer, et al.
Scientific Reports|January 18, 2014
TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivoPeter Horak, Erwin Tomasich, Petr Vaňhara, et al.
Plos One|March 3, 2023
Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective studyCarmen Leser, Georg Dorffner, Maximilian Marhold, et al.
Oncoimmunology|November 29, 2023
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancerMaximilian Marhold, Simon Udovica, Anna Halstead, et al.
Cancers|February 25, 2023
Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast CancerEva Welsch, Eva Schuster, Michael Krainer, et al.
Pageof 4